Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing - R3

This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (HI and Territories), and 01312 (NV).

Effective Date: July 31, 2020
Summary of Article Changes:
Addition of coding to Group 1:
C54.1 - Malignant neoplasm of endometrium
Z15.04 - Genetic susceptibility to malignant neoplasm of endometrium

Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.

 

            Last Updated Thu, 09 Jul 2020 17:33:17 +0000